Clinical-stage biotechnology company Neurizon Therapeutics (ASX: NUZ) has continued its success in proving the versatility of ...

Hydrogen transport solutions developer Provaris Energy (ASX: PV1) has signed a memorandum of understanding (MoU) with global ...

International financial analytics specialist S&P Global says that, while the reaction by commodity and financial markets to ...

Plant-based biotechnology company BPH Global (ASX: BP8) has reported first-month revenue of approximately $150,000 from its ...

Singular Health Group (ASX: SHG) has signed a binding $2 million contract with US firm Provider Network Solutions (PNS) for ...

Fraud-prevention software developer Adveritas (ASX: AV1) has completed an $8.5 million placement to existing shareholders and new institutional investors ...

Amplia Therapeutics (ASX: ATX) continues to make excellent progress with focal adhesion kinase (FAK) inhibitor narmafotinib, ...